16 results on '"C. Downham"'
Search Results
2. Outcomes following small bowel obstruction due to malignancy in the national audit of small bowel obstruction
- Author
-
Thomas M. Drake, Matthew J. Lee, Adele E. Sayers, John Abercrombie, Austin Acheson, Derek Alderson, Iain Anderson, Mike Bradburn, Michael Davies, Zaed Hamady, Daniel Hind, Marianne Hollyman, Sarah Hare, Ellen Lee, John Northover, Christopher Lewis, Paul J. Marriott, Nick Maynard, Malcolm McFall, Aravinth Muragananthan, David Murray, Pritam Singh, Gillian Tierney, Azmina Verjee, Ciaran Walsh, Jonathan RL. Wild, Timothy Wilson, S. Abbott, Y. Abdulaal, S. Afshar, M. Akhtar, D. Anderson, S. Appleton, D. Bandyopadhyay, G. Bashir, N. Behar, S. Bhandari, G. Branagan, R. Boulton, C. Borg, G. Bouras, J. Boyle, H. Brewer, L. Brown, C. Briggs, M. Cartmell, S. Chan, N. Chandratreya, P. Conaghan, J. Cornish, D. Cotton, P. Coyne, J. Crozier, T. Cook, P. Cunha, N. Curtis, A. Day, S. Dayal, R. Dennis, P. Dent, H. Dowson, R. Fallaize, S. Farag, M. El Farran, G. Faulkner, P. Giordano, T. Grey, V. Halahakoon, J. Hannay, A. Harikrishnan, S. Holtham, P. Hawkin, C. Hall, L. Hancock, J. Hartley, F. Howse, R. Kallam, G. Kakaniaris, S. Kelly, S. Lockwood, D. Leinhardt, B. Levy, R. Lal, T. Lazim, J. Lund, R. Lunevicius, P. Mathur, K. Maude, D. McArthur, B. McIlroy, A. Miles, S. Moug, M. Mondragon-Pritchard, D. Messenger, M. Mullan, A. Myers, K. Muhammad, C. Mason, J. Sarveswaran, V. Shatkar, B. Singh, B. Skelly, S. Subramonia, M. Swinscoe, B. Thava, C. Thorn, S. Panagiotopoulos, P. Patel, J. Phillips, I. Peristerakis, A. Qureshi, M. Saunders, P. Shah, A. Sheel, S. Siddiqui, P. Skaife, N. Smart, I. Smith, L. Stevenson, N. Stylianides, J. Steinke, B. Stubbs, R. Thompson, M. Varcada, D. Vimalachandran, I. Virlos, J. Watfah, N. Watson, M. Walker, N. Ventham, H. West, J. Wilson, S. Wijeyekoon, J. Ah-Chuen, T. Ahmed, F. Akram, E. Aldred, A. Ali, M. Aly, A. Amajuoyi, V. Amin, A. Andreou, A. Ansari, R. Ardley, F. Arshad, O. Ashour, A. Asour, F. Ayoub, H. Azeem, B. Azhar, C. Baillie, J. Barker, B. Barkham, R. Baron, J. Barrie, E. Barry-Yarrow, N. Battersby, G. Bazoua, C. Berger, S. Bhasin, S. Biggs, C. Bisset, N. Blencowe, A. Boddy, C. Boereboom, M. Bogdan, R. Bogle, P. Bohra, H. Bolkan, M. Boyer, J. Broadhurst, E. Brown, J. Brown, K. Burns, K. Butcher, C. Capper, T. Cash, J. Chapman, S. Chapman, A. Charalabopoulos, C. Cheek, S. Chok, W. Choong, J. Chowdhury, P. Coe, G. Conn, N. Cook, S. Cooper, C. Cox, R. Crook, G. Cuffolo, L. da Silva, B. Das, M. Davenport, J. Davies, T. Davies, S. Dean, G. Demetriou, F. Dengu, H. Dent, G. Di Benedetto, S. Dindyal, E. Donnelly, E. Douka, C. Downham, H. Edent, K. Edgerton, M. El-Sharif, O. Elamin, N. Elsaid, J. Evans, M. Evans, R. Ewe, A. Ewing, H. Ferguson, O. Fisher, J. Fletcher, A. Forouzanfar, A. Foster, R. Fox, N. Francis, V. Fretwell, D. Fung, E. Gammeri, J. Garnham, A. Geraghty, A. Gilbert, M. Gill, M. Gillespie, J. Glasbey, A. Golder, N. Green, E. Groundwater, T. Grove, H. Habib, J. Haddow, C. Halkias, A. Hampson, T. Hanna, R. Harries, K. Harvey, J. Hawkins, R. Healy, R. Heartshorne, S. Heller, L. Hendra, P. Herrod, N. Heywood, G. Hicks, P. Ng, C. Hope, P. Hopley, T. Hossain, S. Hossaini, T. Hubbard, A. Humphreys, H. Ikram, M. Ioannis, M. Iqbal, J. Jatania, P. Jenkinson, S. Jokhan, A. Jones, C. Jones, L. Jones, H. Joshi, K. Joshi, M. Joy, P. Jull, E. Kane, R. Kanitkar, S. Kauser, F. Kazmi, M. Kedrzycki, J. Kendall, T. Khan, G. King, A. Kisiel, C. Kitsis, I. Kolawole, S. Kosasih, A. Kosti, A. Kotb, A. Lau, G. Lafaurie, A. Lazzaro, R. Lefroy, H. Lennon, K. Leong, E. Lim, J. Lim, S. Lindley, D. Liu, P. Lloyd, D. Locker, C. Lowe, A. Lunt, S. Lutfi, A. Luther, S. Luwemba, P. Mahankali-Rao, D. Mai, S. Majid, A. Malik, N. Manu, R. Mapara, C. Martin, J. Martin, L. Massey, J. Mathias, S. McCain, S. McCluney, A. McNair, P. Mekhail, J. Merchant, L. Merker, S. Mir, P. Mistry, V. Miu, M. Moat, E. Mohamed, I. Mohamed, N. Moore, L. Moretti, H. Morris, T. Morrison, J. Moss, D. Mountford, R. Moynihan, D. Muldoon-Smith, J. Mulholland, E. Murgitroyd, K. Murugaiyan, I. Mykoniatis, G. Nana, T. Nash, A. Nassar, R. Newton, K. Nguyen, F. Nicholas, M. Noor, J. Nowers, C. Nugent, A. Nunn, J. O'Callaghan, R. O'Hara, A. O'Neill, J. Olivier, D. Osei-Bordom, L. Osgood, B. Panchasara, R. Parks, H. Patel, K. Pawelec, C. Payne, K. Pearson, G. Perin, B. Petronio, L. Phelan, C. Pisaneschi, J. Pitt, L. Ponchietti, A. Powell, A. Powell-Chandler, N. Pranesh, V. Proctor, N. Qureshi, M. Rahman, Z. Rai, S. Ramcharan, K. Rangarajan, M. Rashid, H. Reader, A. Rehman, S. Rehan, C. Rengifo, N. Richardson, A. Robinson, D. Robinson, B. Rossi, F. Rutherford, I. Sadien, T. Saghir, K. Sahnan, G. Salahia, B. Scott, K. Scott, A. Seager, S. Seal, E. Sezen, F. Shaban, M. Shahmohammadi, A. Shamsiddinova, S. Shankar, A. Sharpe, T. Shields, M. Shinkwin, J. Shurmer, A. Siddika, R. Simson, S. Singh, J. Sivaraj, A. Skinner, C. Smart, F. Smith, R. Smith, A. Sreedhar, E. Stewart-Parker, M. Stott, N. Symons, T. Taj, J. Tam, K. Tan, S. Tani, D. Tao, K. Thippeswamy, C. Thomas, E. Thompson, C. Thompson-Reil, F. Tongo, G. Toth, A. Turnbull, J. Turnbull, T. Wade, A. Wafi, K. Waite, N. Walker, T. Walker, U. Walsh, S. Wardle, R. Warner, J. Watt, J. Watts, J. Wayman, C. Weegenaar, M. West, M. Whyler, L. Whitehurst, M. Wiggans, G. Williams, R. Williams, A. Williamson, J. Williamson, A. Winter, L. Wolpert, J. Wong, G. van Boxel, E. Yeap, S. Zaman, B. Zappa, D. Zosimas, O. Anderson, A. Athem, M. Athersmith, T. Badenoch, S. Barker, S. Bellam, T. Boam, M. Boland, L. Blake, O. Brown, M. Butler, B. Byrne, L. Campbell, M. Chow, K. Da Costa, J. Cutting, M. Deputy, L. Devoto, P. Doody, N. Ekpete, M. Eljaafari, K. Exarchou, M. Faoury, E. Farinella, C. Gill, M. Goh, T. Gregoir, S. Growcott, S. Gunasekaran, G. Harris, R. Heard, B. Hobson, N. Iqbal, R. Jain, P. Kang, M. Khan, S. Korambayil, S. Kouris, K. Kshatriya, S. Kumar, K. Lee, S. Mahroof, K. Malik, K. Mann, S. Mansour, R. Martin, S. McKay, N. McKinley, D. McWhirter, K. Mellor, A. Mishra, K. Mockford, V. Morrison-Jones, C. Ng, R. Nunn, S. O'Neill, O. Oke, N. Obeid, R. Patel, S. Patel, K. Plunkett-Reed, M. Pouzi, S. Pywell, E. Richards, P. Sinclair, N. Slim, G. Spence, M. Swinkin, W. Tahir, K. Takacs, N. Tanner, M. Taylor, C. Valero, M. Venn, M. Venza, T. Yeong, and Nicola S. Fearnhead
- Subjects
Male ,medicine.medical_specialty ,Colorectal cancer ,030230 surgery ,Malignancy ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Internal medicine ,Intestinal Neoplasms ,Intestine, Small ,Humans ,Medicine ,Prospective Studies ,Aged ,business.industry ,Mortality rate ,Hazard ratio ,Cancer ,General Medicine ,medicine.disease ,United Kingdom ,Bowel obstruction ,Oncology ,Abdominal Neoplasms ,030220 oncology & carcinogenesis ,Cohort ,Female ,Surgery ,business ,Intestinal Obstruction ,Cohort study - Abstract
Introduction\ud \ud Patients with cancer who develop small bowel obstruction are at high risk of malnutrition and morbidity following compromise of gastrointestinal tract continuity. This study aimed to characterise current management and outcomes following malignant small bowel obstruction.\ud \ud \ud \ud Methods\ud \ud A prospective, multicentre cohort study of patients with small bowel obstruction who presented to UK hospitals between 16th January and 13th March 2017. Patients who presented with small bowel obstruction due to primary tumours of the intestine (excluding left-sided colonic tumours) or disseminated intra-abdominal malignancy were included. Outcomes included 30-day mortality and in-hospital complications. Cox-proportional hazards models were used to generate adjusted effects estimates, which are presented as hazard ratios (HR) alongside the corresponding 95% confidence interval (95% CI). The threshold for statistical significance was set at the level of P ≤ 0.05 a-priori.\ud \ud \ud \ud Results\ud \ud 205 patients with malignant small bowel obstruction presented to emergency surgery services during the study period. Of these patients, 50 had obstruction due to right sided colon cancer, 143 due to disseminated intraabdominal malignancy, 10 had primary tumours of the small bowel and 2 patients had gastrointestinal stromal tumours. In total 100 out of 205 patients underwent a surgical intervention for obstruction. 30-day in-hospital mortality rate was 11.3% for those with primary tumours and 19.6% for those with disseminated malignancy. Severe risk of malnutrition was an independent predictor for poor mortality in this cohort (adjusted HR 16.18, 95% CI 1.86 to 140.84, p = 0.012). Patients with right-sided colon cancer had high rates of morbidity.\ud \ud \ud \ud Conclusions\ud \ud Mortality rates were high in patients with disseminated malignancy and in those with right sided colon cancer. Further research should identify optimal management strategy to reduce morbidity for these patient groups.
- Published
- 2019
- Full Text
- View/download PDF
3. Oral abstracts 1: SpondyloarthropathiesO1. Detecting axial spondyloarthritis amongst primary care back pain referrals
- Author
-
C. Harris, D. Remedios, T. Aptowitzer, A. Keat, L. Hamilton, G. Guile, A. Belkhiri, D. Newman, A. Toms, A. Macgregor, K. Gaffney, L. Morton, G. T. Jones, A. G. MacDonald, C. Downham, G. J. Macfarlane, W. Tillett, D. Jadon, D. Wallis, L. Costa, N. Waldron, N. Griffith, C. Cavill, E. Korendowych, C. de Vries, N. McHugh, O. Iaremenko, D. Fedkov, P. Emery, D. Baeten, J. Sieper, J. Braun, D. van der Heijde, I. McInnes, J. Van Laar, R. Landewe, B. P. Wordsworth, J. Wollenhaupt, H. Kellner, I. Paramarta, A. Bertolino, A. M. Wright, W. Hueber, N. Sofat, C. Smee, M. Hermansson, J. Wajed, K. Sanyal, P. Kiely, M. Howard, F. A. Howe, T. R. Barrick, A. M. Abraham, M. S. Pearce, K. D. Mann, R. M. Francis, F. Birrell, A. Carr, I. Macleod, W.-F. Ng, A. Kavanaugh, C. Chattopadhyay, D. Gladman, P. Mease, G. Krueger, W. Xu, N. Goldstein, A. Beutler, X. Baraliakos, D. D. Laurent, S. Gsteiger, P. G. Conaghan, C. G. Peterfy, J. DiCarlo, E. Olech, A. R. Alberts, J. A. Alper, J. Devenport, A. M. Anisfeld, O. M. Troum, P. Cooper, M. Gimpel, G. Deakin, K. Jameson, M. Godtschailk, S. Gadola, M. Stokes, C. Cooper, C. Gordon, K. Kalunian, M. Petri, V. Strand, B. Kilgallen, A. Barry, D. Wallace, C. A. Flurey, M. Morris, J. Pollock, R. Hughes, P. Richards, and S. Hewlett
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Ankylosing spondylitis ,Rheumatology ,business.industry ,Internal medicine ,medicine ,Pharmacology (medical) ,medicine.disease ,business - Abstract
Background: Inflammatory back pain (IBP) is an early feature of ankylosing spondylitis (AS) and its detection offers the prospect of early diagnosis of AS. However, since back pain is very common but only a very small minority of back pain sufferers have ASpA or AS, screening of back pain sufferers for AS is problematic. In early disease radiographs are often normal so that fulfilment of diagnostic criteria for AS is impossible though a diagnosis of axial SpA can be made if MRI evidence of sacroiliitis is present. This pilot study was designed to indicate whether a cost-effective pick up rate for ASpA/early AS could be achieved by identifying adults with IBP stratified on the basis of age. Methods: Patients aged between 18 and 45 years who were referred to a hospital physiotherapy service with back pain of more than 3 months duration were assessed for IBP. All were asked to complete a questionnaire based on the Berlin IBP criteria. Those who fulfilled IBP criteria were also asked to complete a second short questionnaire enquiring about SpA comorbidities, to have a blood test for HLA-B27 and CRP level and to undergo an MRI scan of the sacroiliac joints. This was a limited scan, using STIR, diffusion-weighted, T1 and T2 sequences of the sacroiliac joints to minimize time in the scanner and cost. The study was funded by a research grant from Abbott Laboratories Ltd. Results: 50 sequential patients agreed to participate in the study and completed the IBP questionnaire. Of these 27 (54%) fulfilled criteria for IBP. Of these, 2 patients reported a history of an SpA comorbidity - 1 psoriasis; 1 ulcerative colitis - and 3 reported a family history of an SpA comorbidity - 2 psoriasis; 1 Crohn's disease. 4 were HLA-B27 positive, though results were not available for 7. Two patients had marginally raised CRP levels (6, 10 -NR ≤ 5). 19 agreed to undergo MRI scanning of the sacroiliac joints and lumbar spine; 4 scans were abnormal, showing evidence of bilateral sacroiliitis on STIR sequences. In all cases the changes met ASAS criteria but were limited. Of these 4 patients 3 were HLA-B27 positive but none gave a personal or family history of an SpA-associated comorbidity and all had normal CRP levels. Conclusions: This was a pilot study yielding only limited conclusions. However, it is clear that: Screening of patients referred for physiotherapy for IBP is straightforward, inexpensive and quick. It appears that IBP is more prevalent in young adults than overall population data suggest so that targeting this population may be efficient. IBP questionnaires could be administered routinely during a physiotherapy assessment. HLA-B27 testing in this group of patients with IBP is a suitable screening tool. The sacroiliac joint changes identified were mild and their prognostic significance is not yet clear so that the value of early screening needs further evaluation. Disclosure statement: C.H. received research funding for this study from Abbott. A.K. received research funding for this study, and speaker and consultancy fees, from Abbott. All other authors have declared no conflicts of interest
- Published
- 2017
4. Medical Optimisation Can Reduce Morbidity and Mortality Associated with Elective Aortic Aneurysm Repair
- Author
-
S. Vig, Matt M. Thompson, G. Horne, Edward Choke, I.M. Loftus, J. Blundell, J. Dawson, and C. Downham
- Subjects
Male ,medicine.medical_specialty ,Medical optimisation ,Respiratory Tract Diseases ,Comorbidity ,Preoperative care ,Risk Assessment ,Aortic aneurysm ,Aneurysm ,Predictive Value of Tests ,Internal medicine ,Preoperative Care ,medicine ,Odds Ratio ,Humans ,Prospective Studies ,cardiovascular diseases ,Mortality ,Prospective cohort study ,Aorta ,Aged ,Medicine(all) ,Aortic aneurysm repair ,Aortic Aneurysm, Thoracic ,business.industry ,Patient Selection ,Odds ratio ,Perioperative ,medicine.disease ,Surgery ,Aortic Aneurysm ,Logistic Models ,Treatment Outcome ,Cardiovascular Diseases ,Elective Surgical Procedures ,Research Design ,Predictive value of tests ,cardiovascular system ,Female ,Kidney Diseases ,Morbidity ,Cardiology and Cardiovascular Medicine ,business ,Vascular Surgical Procedures ,Aortic Aneurysm, Abdominal - Abstract
Objectives Patients with aortic aneurysms have significant comorbidities which influence outcome. Our practice includes comprehensive assessment to identify comorbidities, allowing subsequent medical optimisation prior to aneurysm repair. The aim of this study was to assess this process and to identify any factors predictive of outcome. Design Prospective observational study. Materials Medical case notes of 200 patients referred with aortic pathology. Methods Data analysed included preoperative, perioperative and postoperative factors. Multiple logistic regression analysis was performed to identify predictors of outcome. Results Following assessment 17 patients (8.5%) were found to be unfit for intervention and 165 patients (82.5%) proceeded to aneurysm repair. In this group assessment uncovered previously undiagnosed cardiac, respiratory and renal comorbidity in 19%, 57% and 29% of patients respectively. Multiple logistic regression analysis indicated that optimisation by a renal physician reduced post-operative renal impairment (OR 0.12, 95% CI 0.03–0.45, P = 0.002) while optimisation by a cardiologist reduced respiratory complications (OR 0.7, 95% CI 0.05–0.99, P = 0.049). An abnormal echocardiogram was associated with pneumonia (OR 6.9, 95% CI 1.6–29, P = 0.01) and death (OR 7.9, 95% CI 1.15–54, P = 0.036). Conclusion Pre-operative assessment identifies previously undiagnosed comorbidity in a significant proportion of patients. Subsequent medical optimisation may reduce post-operative morbidity and mortality.
- Published
- 2007
- Full Text
- View/download PDF
5. Direct effects of diazepam on emotional processing in healthy volunteers
- Author
-
Philip J. Cowen, C. Downham, Catherine J. Harmer, and Susannah E. Murphy
- Subjects
Adult ,Male ,medicine.medical_specialty ,Serotonin ,medicine.drug_class ,medicine.medical_treatment ,Audiology ,Anxiolytic ,Emotional processing ,Developmental psychology ,Hypnotic ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Double-Blind Method ,Memory ,medicine ,Reaction Time ,Humans ,Hypnotics and Sedatives ,Attention ,Healthy volunteers ,Original Investigation ,Pharmacology ,Attentional bias ,Diazepam ,Electromyography ,Startle ,Cognition ,Recognition, Psychology ,3. Good health ,030227 psychiatry ,Facial Expression ,Alertness ,Anticonvulsant ,Social Perception ,Sedative ,Mental Recall ,Anxiety ,Female ,Perception ,medicine.symptom ,Psychology ,Facial expression recognition ,030217 neurology & neurosurgery ,Psychomotor Performance ,medicine.drug - Abstract
RATIONALE: Pharmacological agents used in the treatment of anxiety have been reported to decrease threat relevant processing in patients and healthy controls, suggesting a potentially relevant mechanism of action. However, the effects of the anxiolytic diazepam have typically been examined at sedative doses, which do not allow the direct actions on emotional processing to be fully separated from global effects of the drug on cognition and alertness. OBJECTIVES: The aim of this study was to investigate the effect of a lower, but still clinically effective, dose of diazepam on emotional processing in healthy volunteers. MATERIALS AND METHODS: Twenty-four participants were randomised to receive a single dose of diazepam (5 mg) or placebo. Sixty minutes later, participants completed a battery of psychological tests, including measures of non-emotional cognitive performance (reaction time and sustained attention) and emotional processing (affective modulation of the startle reflex, attentional dot probe, facial expression recognition, and emotional memory). Mood and subjective experience were also measured. RESULTS: Diazepam significantly modulated attentional vigilance to masked emotional faces and significantly decreased overall startle reactivity. Diazepam did not significantly affect mood, alertness, response times, facial expression recognition, or sustained attention. CONCLUSIONS: At non-sedating doses, diazepam produces effects on attentional vigilance and startle responsivity that are consistent with its anxiolytic action. This may be an underlying mechanism through which benzodiazepines exert their therapeutic effects in clinical anxiety.
- Published
- 2007
6. P.3.20 The effect of a low dose of diazepam on emotional processing in healthy volunteers
- Author
-
Susannah E. Murphy, Catherine J. Harmer, P J Cowen, and C. Downham
- Subjects
Pharmacology ,business.industry ,Low dose ,Emotional processing ,Psychiatry and Mental health ,Neurology ,Anesthesia ,Healthy volunteers ,Medicine ,Pharmacology (medical) ,Neurology (clinical) ,business ,Diazepam ,Biological Psychiatry ,medicine.drug - Published
- 2007
- Full Text
- View/download PDF
7. Economic analysis of scintillation camera usage in nuclear medicine facilities
- Author
-
Ronald G. Evens and Max C. Downham
- Subjects
Lung Diseases ,Time Factors ,Discount points ,law.invention ,law ,Photography ,Medicine ,Economic analysis ,Humans ,Radiology, Nuclear Medicine and imaging ,Economics, Hospital ,Fixed cost ,Radionuclide Imaging ,Gamma camera ,Scintillation ,Brain Diseases ,business.industry ,Liver Diseases ,Thyroid Diseases ,United States ,Cost analysis ,Costs and Cost Analysis ,Profitability index ,Bone Diseases ,Nuclear Medicine ,business ,Nuclear medicine ,Utilization rate - Abstract
Economic principles and analytic methods have been adapted to the evaluation of scintillation camera profitability in ten hospital nuclear medicine facilities. Allocation of fixed costs to each study has been demonstrated by the development of a gamma camera utilization rate (GCUR), and profitability determined by break-even point analysis. In these hospitals, the break-even point varied from 7 to 28% GCUR. Such an analysis can be performed in existing and contemplated nuclear medicine facilities for economic decisions related to obtaining new equipment and personnel. Similar evaluation can be used to justify and determine reasonable charges for nuclear medicine procedures.
- Published
- 1971
8. ARthroscopy in Knee OsteoArthritis (ARK-OA): a multicentre study assessing compliance to national guidelines.
- Author
-
Khatri C, Dickenson E, Ahmed I, Bretherton C, Ranaboldo T, Shaw C, Quarcoopome J, Plastow R, Downham C, Rasidovic D, Plant C, and Barlow T
- Subjects
- Humans, Knee Joint, Retrospective Studies, United Kingdom, Arthroscopy, Osteoarthritis, Knee surgery
- Abstract
Introduction: The use of arthroscopy to alleviate the symptoms of osteoarthritis has been questioned by recent high quality evidence. This has led to the development of guidelines by specialist and national bodies advocating against its use., Aims: To examine the trends of the rates of arthroscopy in patients with knee osteoarthritis over the past five years and determining compliance with guidelines., Methods: Multi-centre, retrospective audit in five hospital trusts in the United Kingdom. The number of arthroscopies performed by month from 2013 to 2017 was identified through hospital coding. Fifty randomly selected records from the year 2017 were further analysed to assess compliance with NICE guidelines., Results: Between 2013 and 2017, the number of arthroscopies performed annually in five trusts dropped from 2028 to 1099. In the year 2017, 17.7% of patients with no mechanical symptoms and moderate-to-severe arthritis pre-operatively had arthroscopy., Conclusion: Knee arthroscopy continues to be used as a treatment for osteoarthritis, against national guidelines. Whilst overall numbers are declining, further interventions, including implementation of high-quality conservative care is required to further eliminate unnecessary procedures., (© 2021. The Author(s), under exclusive licence to Springer-Verlag France SAS part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
9. Season of infectious mononucleosis as a risk factor for multiple sclerosis: A UK primary care case-control study.
- Author
-
Downham C, Visser E, Vickers M, and Counsell C
- Subjects
- Adolescent, Adult, Case-Control Studies, Female, Humans, Infectious Mononucleosis complications, Male, Middle Aged, Multiple Sclerosis etiology, Odds Ratio, Risk Factors, United Kingdom epidemiology, Vitamin D analysis, Young Adult, Infectious Mononucleosis epidemiology, Multiple Sclerosis epidemiology
- Abstract
Background: Infectious mononucleosis (IM) and vitamin D deficiency are both risk factors for multiple sclerosis (MS)., Objective: We wished to establish if IM in the winter months when vitamin D levels are low may be a greater risk factor for MS than IM in the summer months., Methods: We identified all patients with MS diagnosed aged 16-60 in a large primary care database in the United Kingdom and matched each by age, sex, general practice and observation period with up to six controls. We identified a coded diagnosis of IM prior to the index date (date of diagnosis). Logistic regression was used to calculate the odds ratio for prior IM exposure in cases versus controls and for winter versus summer exposure in cases and controls with prior IM exposure., Results: Based on 9247 cases and 55,033 matched controls (246 and 846 with prior IM respectively), IM was associated with the development of MS (OR 1.77, 95%CI 1.53-2.05) but there was no evidence that IM in the winter as opposed to summer was associated with developing MS (OR 1.09, 95%CI 0.72-1.66)., Conclusion: We found no evidence that the season of IM influences the risk of subsequent MS., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
10. The Efficacy of Medial Patellofemoral Ligament Reconstruction Combined with Tibial Tuberosity Transfer in the Treatment of Patellofemoral Instability.
- Author
-
Boutefnouchet T, Downham C, Bassett J, Thompson P, and Sprowson A
- Abstract
A systematic review of the literature was undertaken to evaluate the efficacy of medial patellofemoral ligament (MPFL) reconstruction combined with tibial tuberosity transfer (TTT) in the treatment of patellofemoral instability. Using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, a systematic search was carried out to identify and review the published literature pertinent to MFPL reconstruction combined with TTT. Relevant studies were critically appraised with narrative data synthesis. Studies that met the eligibility criteria were suitable for appraisal and consisted of case series and therapeutic series (levels IV & III). All studies had inherent variations in outcomes reporting and limited follow-up. Combined treatment offers restoration of normal anatomy, thus adding clinical value to the currently recommended anatomic approach to MPFL reconstruction. Nevertheless, the current body of evidence does not determine the threshold at which patellofemoral axis requires the need for adjunctive distal realignment as opposed to MPFL reconstruction alone. This review highlighted numerous recurring limitations in the conduct and presentation of the studies, which inadvertently mitigated the interpretation of their results. Future priority should be awarded to larger randomised controlled trials utilising validated patient reported outcome measures.
- Published
- 2016
- Full Text
- View/download PDF
11. Arthroscopy in knee osteoarthritis: a systematic review of the literature.
- Author
-
Barlow T, Downham C, and Griffin D
- Subjects
- Arthroscopy, Humans, Pain Measurement, Randomized Controlled Trials as Topic, Tibial Meniscus Injuries, Treatment Outcome, Debridement methods, Osteoarthritis, Knee surgery
- Abstract
Knee arthroscopy has historically been a common treatment for knee osteoarthritis. A Cochrane review of the literature up to 2006 has resulted in guidance that arthroscopy is not effective in knee osteoarthritis. It cited that deficiencies in the evidence base prevented widespread acceptance of the recommendations. The aim of this review is to update the evidence base for the efficacy of arthroscopy in knee osteoarthritis. The authors searched CINHAL, EMBASE, MEDLINE, and CENTRAL for randomised controlled trials that compared arthroscopic surgery in knee osteoarthritis with a control group (e.g. lavage, best medical care). The primary outcome measure was patient reported functional outcome. The study methodology was registered on Prospero, a systematic review register: Registration number CRD42012002891. Five randomised controlled trials included 516 patients, almost double the 271 episodes contained in previous reviews. Two high quality studies, according to the Jadad classification, published since the Cochrane review, addressed many of the methodological flaws criticised in previous reviews. However, certain subgroup analyses (e.g. patients with meniscal tears and mechanical symptoms) are still underpowered.
- Published
- 2015
12. Global prevalence of ankylosing spondylitis.
- Author
-
Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, and Macfarlane GJ
- Subjects
- Africa epidemiology, Asia epidemiology, Europe epidemiology, Global Health, HLA-B27 Antigen genetics, Humans, Latin America epidemiology, North America epidemiology, Prevalence, Spondylitis, Ankylosing genetics, Spondylitis, Ankylosing epidemiology
- Abstract
Objectives: For effective health care provision, knowledge of disease prevalence is paramount. There has been no systematic endeavour to establish continent-based AS estimates, however, prevalence is thought to vary by country and background HLA-B27 prevalence. This study aimed to estimate AS prevalence worldwide and to calculate the expected number of cases., Methods: A systematic literature search was conducted. Prevalence data were extracted and used to calculate the mean prevalence by continent and the expected number of cases based on country-specific prevalence (or, if missing, the prevalence from neighbouring countries). A second estimate was made using the prevalence from countries with similar HLA-B27 prevalences if a country-specific prevalence estimate was not available., Results: The mean AS prevalence per 10,000 (from 36 eligible studies) was 23.8 in Europe, 16.7 in Asia, 31.9 in North America, 10.2 in Latin America and 7.4 in Africa. Additional estimates, weighted by study size, were calculated as 18.6, 18.0 and 12.2 for Europe, Asia and Latin America, respectively. There were sufficient studies to estimate the number of cases in Europe and Asia, calculated to be 1.30-1.56 million and 4.63-4.98 million, respectively., Conclusion: This study represents the first systematic attempt to collate estimates of AS prevalence into a single continent-based estimate. In addition, the number of expected cases in Europe and Asia was estimated. Through reviewing the current literature, it is apparent that the continuing conduct of epidemiological studies of AS prevalence is of great importance, particularly as diagnostic capabilities improve and with the recent development of the criteria for axial SpA.
- Published
- 2014
- Full Text
- View/download PDF
13. High-sensitivity monoclonal antibodies specific for homoserine lactones protect mice from lethal Pseudomonas aeruginosa infections.
- Author
-
Palliyil S, Downham C, Broadbent I, Charlton K, and Porter AJ
- Subjects
- 4-Butyrolactone immunology, Animals, Antibodies, Monoclonal genetics, Antibodies, Monoclonal immunology, Caenorhabditis elegans drug effects, Caenorhabditis elegans microbiology, Cross Reactions, Immune Sera, Mice, Mice, Inbred Strains, Pancreatic Elastase immunology, Pancreatic Elastase metabolism, Peptide Library, Pseudomonas Infections microbiology, Pseudomonas Infections mortality, Quorum Sensing, Sheep, 4-Butyrolactone analogs & derivatives, Antibodies, Monoclonal pharmacology, Pseudomonas Infections prevention & control, Pseudomonas aeruginosa pathogenicity
- Abstract
A number of bacteria, including pathogens like Pseudomonas aeruginosa, utilize homoserine lactones (HSLs) as quorum sensing (QS) signaling compounds and engage in cell-to-cell communication to coordinate their behavior. Blocking this bacterial communication may be an attractive strategy for infection control as QS takes a central role in P. aeruginosa biology. In this study, immunomodulation of HSL molecules by monoclonal antibodies (MAbs) was used as a novel approach to prevent P. aeruginosa infections and as tools to detect HSLs in bodily fluids as a possible first clue to an undiagnosed Gram-negative infection. Using sheep immunization and recombinant antibody technology, a panel of sheep-mouse chimeric MAbs were generated which recognized HSL compounds with high sensitivity (nanomolar range) and cross-reactivity. These MAbs retained their nanomolar sensitivity in complex matrices and were able to recognize HSLs in P. aeruginosa cultures grown in the presence of urine. In a nematode slow-killing assay, HSL MAbs significantly increased the survival of worms fed on the antibiotic-resistant strain PA058. The therapeutic benefit of these MAbs was further studied using a mouse model of Pseudomonas infection in which groups of mice treated with HSL-2 and HSL-4 MAbs survived, 7 days after pathogen challenge, in significantly greater numbers (83 and 67%, respectively) compared with the control groups. This body of work has provided early proof-of-concept data to demonstrate the potential of HSL-specific, monoclonal antibodies as theranostic clinical leads suitable for the diagnosis, prevention, and treatment of life-threatening bacterial infections.
- Published
- 2014
- Full Text
- View/download PDF
14. The effect of complementary therapies on post-operative pain control in ambulatory knee surgery: a systematic review.
- Author
-
Barlow T, Downham C, and Barlow D
- Subjects
- Clinical Trials as Topic, Humans, Acupuncture Therapy, Homeopathy, Knee Joint surgery, Pain Management methods, Pain, Postoperative therapy
- Abstract
Ambulatory knee surgery is a common procedure with over 100,000 knee arthroscopies performed in the U.K. in 2010-2011. Pain after surgery can decrease patient satisfaction, delay discharge, and decrease cost effectiveness. Multi-modal therapies, including complementary therapies, to improve pain control after surgery have been recommended. However, a comprehensive review of the literature regarding the use of complementary therapies to enhance pain control after ambulatory knee surgery is lacking, and this article aims to address this deficit. CINHAL, EMBASE, MEDLINE, AMED and CENTRAL databases were searched. Only Randomised Controlled Trials were included. All eligible papers were quality assessed using the Jadad system, and data was extracted using piloted forms. Two independent reviewers performed each stage of the review. Full details of the study methodology can be found on Prospero, a systematic review register. Five studies satisfied our eligibility criteria: three reporting on acupuncture, one on homeopathy, and one on acupoints. Acupoint pressure was the only study that demonstrated reduced pain compared with placebo. This study was the least methodologically robust. Arnica, although demonstrating a significant reduction in swelling, did not affect post-operative pain. Acupuncture did not affect post-operative pain; however, a reduction in ibuprofen use was demonstrated in two studies. Before recommending complementary therapy for routine use in ambulatory knee surgery, further work is required. Two areas of future research likely to bear fruit are demonstrating robust evidence for the effect of acupoint pressure on post-operative pain, and quantifying the positive effect of homeopathic arnica on post-operative swelling., (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
15. Direct effects of diazepam on emotional processing in healthy volunteers.
- Author
-
Murphy SE, Downham C, Cowen PJ, and Harmer CJ
- Subjects
- Adult, Attention drug effects, Diazepam adverse effects, Double-Blind Method, Electromyography, Facial Expression, Female, Humans, Hypnotics and Sedatives adverse effects, Male, Memory drug effects, Mental Recall drug effects, Psychomotor Performance drug effects, Reaction Time drug effects, Recognition, Psychology drug effects, Serotonin physiology, Young Adult, Diazepam pharmacology, Hypnotics and Sedatives pharmacology, Perception drug effects, Social Perception
- Abstract
Rationale: Pharmacological agents used in the treatment of anxiety have been reported to decrease threat relevant processing in patients and healthy controls, suggesting a potentially relevant mechanism of action. However, the effects of the anxiolytic diazepam have typically been examined at sedative doses, which do not allow the direct actions on emotional processing to be fully separated from global effects of the drug on cognition and alertness., Objectives: The aim of this study was to investigate the effect of a lower, but still clinically effective, dose of diazepam on emotional processing in healthy volunteers., Materials and Methods: Twenty-four participants were randomised to receive a single dose of diazepam (5 mg) or placebo. Sixty minutes later, participants completed a battery of psychological tests, including measures of non-emotional cognitive performance (reaction time and sustained attention) and emotional processing (affective modulation of the startle reflex, attentional dot probe, facial expression recognition, and emotional memory). Mood and subjective experience were also measured., Results: Diazepam significantly modulated attentional vigilance to masked emotional faces and significantly decreased overall startle reactivity. Diazepam did not significantly affect mood, alertness, response times, facial expression recognition, or sustained attention., Conclusions: At non-sedating doses, diazepam produces effects on attentional vigilance and startle responsivity that are consistent with its anxiolytic action. This may be an underlying mechanism through which benzodiazepines exert their therapeutic effects in clinical anxiety.
- Published
- 2008
- Full Text
- View/download PDF
16. Medical optimisation can reduce morbidity and mortality associated with elective aortic aneurysm repair.
- Author
-
Dawson J, Vig S, Choke E, Blundell J, Horne G, Downham C, Loftus I, and Thompson MM
- Subjects
- Aged, Aortic Aneurysm epidemiology, Aortic Aneurysm, Abdominal mortality, Aortic Aneurysm, Abdominal surgery, Aortic Aneurysm, Thoracic mortality, Aortic Aneurysm, Thoracic surgery, Cardiovascular Diseases epidemiology, Comorbidity, Female, Humans, Kidney Diseases epidemiology, Logistic Models, Male, Odds Ratio, Predictive Value of Tests, Prospective Studies, Research Design, Respiratory Tract Diseases epidemiology, Risk Assessment, Treatment Outcome, Aortic Aneurysm mortality, Aortic Aneurysm surgery, Elective Surgical Procedures, Patient Selection, Preoperative Care standards, Vascular Surgical Procedures
- Abstract
Objectives: Patients with aortic aneurysms have significant comorbidities which influence outcome. Our practice includes comprehensive assessment to identify comorbidities, allowing subsequent medical optimisation prior to aneurysm repair. The aim of this study was to assess this process and to identify any factors predictive of outcome., Design: Prospective observational study., Materials: Medical case notes of 200 patients referred with aortic pathology., Methods: Data analysed included preoperative, perioperative and postoperative factors. Multiple logistic regression analysis was performed to identify predictors of outcome., Results: Following assessment 17 patients (8.5%) were found to be unfit for intervention and 165 patients (82.5%) proceeded to aneurysm repair. In this group assessment uncovered previously undiagnosed cardiac, respiratory and renal comorbidity in 19%, 57% and 29% of patients respectively. Multiple logistic regression analysis indicated that optimisation by a renal physician reduced post-operative renal impairment (OR 0.12, 95% CI 0.03-0.45, P=0.002) while optimisation by a cardiologist reduced respiratory complications (OR 0.7, 95% CI 0.05-0.99, P=0.049). An abnormal echocardiogram was associated with pneumonia (OR 6.9, 95% CI 1.6-29, P=0.01) and death (OR 7.9, 95% CI 1.15-54, P=0.036)., Conclusion: Pre-operative assessment identifies previously undiagnosed comorbidity in a significant proportion of patients. Subsequent medical optimisation may reduce post-operative morbidity and mortality.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.